A R, Ueki H, Nishioka S, Yamazaki R, Maekawa M, Kitagawa K
Cancer Gene Ther. 2025; .
PMID: 40011711
DOI: 10.1038/s41417-025-00879-8.
OReilly D, Buchanan P
Bioelectricity. 2024; 4(2):81-91.
PMID: 39350777
PMC: 11441368.
DOI: 10.1089/bioe.2022.0007.
Liu Y, Ye Q, Li J, Bai L, Zhang W, Wang S
Sci Rep. 2024; 14(1):22596.
PMID: 39349535
PMC: 11442943.
DOI: 10.1038/s41598-024-73062-y.
Huang Y, Chen S, Yao N, Lin S, Zhang J, Xu C
Oncoscience. 2024; 11:69-91.
PMID: 39318358
PMC: 11420906.
DOI: 10.18632/oncoscience.610.
Feng D, Gao J, Liu R, Liu W, Gao T, Yang Y
Protein Cell. 2024; 15(10):744-765.
PMID: 38476024
PMC: 11443453.
DOI: 10.1093/procel/pwae010.
The role of hypoxia and radiation in developing a CTCs-like phenotype in murine osteosarcoma cells.
Quartieri M, Puspitasari A, Vitacchio T, Durante M, Tinganelli W
Front Cell Dev Biol. 2023; 11:1222809.
PMID: 38033871
PMC: 10687637.
DOI: 10.3389/fcell.2023.1222809.
Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K, Kaczor J, Soltyk A, Szymanska N, Stecko J, Sleziak J
Int J Mol Sci. 2023; 24(21).
PMID: 37958980
PMC: 10650338.
DOI: 10.3390/ijms242115995.
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li Y, Fang Y, Lyu Z, Zhu Y, Yang L
J Transl Med. 2023; 21(1):686.
PMID: 37784157
PMC: 10546755.
DOI: 10.1186/s12967-023-04575-9.
Nanodelivery systems: An efficient and target-specific approach for drug-resistant cancers.
Ashique S, Garg A, Hussain A, Farid A, Kumar P, Taghizadeh-Hesary F
Cancer Med. 2023; 12(18):18797-18825.
PMID: 37668041
PMC: 10557914.
DOI: 10.1002/cam4.6502.
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies.
Zhao Y, Xing C, Deng Y, Ye C, Peng H
Genes Dis. 2023; 11(1):234-251.
PMID: 37588219
PMC: 10425810.
DOI: 10.1016/j.gendis.2023.02.039.
A recombinant adenovirus vector containing the receptor gene for the treatment of triple-negative breast cancer.
A R, Kunimura N, Tominaga S, Hirata E, Nishioka S, Uesugi M
Front Oncol. 2023; 13:1147668.
PMID: 37064130
PMC: 10090503.
DOI: 10.3389/fonc.2023.1147668.
Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity.
Park C, Lee M, Lee S, Kang D, Park S, Lee D
Noncoding RNA Res. 2023; 8(3):273-281.
PMID: 36949748
PMC: 10025963.
DOI: 10.1016/j.ncrna.2023.03.001.
A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma.
Lin D, Chen Z, Zeng Y, Ding Y, Zhao L, Xu Q
BMC Med Genomics. 2023; 16(1):2.
PMID: 36611208
PMC: 9826587.
DOI: 10.1186/s12920-023-01431-z.
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications.
Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S
J Hematol Oncol. 2022; 15(1):160.
PMID: 36319992
PMC: 9628128.
DOI: 10.1186/s13045-022-01358-5.
Znhit1 and HIF-2α are correlated with cancer stem cell markers in breast cancer patients.
Ebeid S, Abd El Moneim N, El-Benhawy S, Ramadan R, Ismail S
Sci Rep. 2022; 12(1):13918.
PMID: 35978075
PMC: 9385614.
DOI: 10.1038/s41598-022-18133-8.
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.
Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M
Mol Cancer. 2022; 21(1):144.
PMID: 35836256
PMC: 9281132.
DOI: 10.1186/s12943-022-01616-7.
Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis.
Moriondo G, Scioscia G, Soccio P, Tondo P, De Pace C, Sabato R
Int J Mol Sci. 2022; 23(11).
PMID: 35682972
PMC: 9181687.
DOI: 10.3390/ijms23116294.
Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 Sponging miR-191-5p.
Jing X, Du L, Shi S, Niu A, Wu J, Wang Y
Front Pharmacol. 2022; 13:806682.
PMID: 35652045
PMC: 9149248.
DOI: 10.3389/fphar.2022.806682.
Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer.
Naki T, Aderibigbe B
Pharmaceutics. 2022; 14(5).
PMID: 35631634
PMC: 9145018.
DOI: 10.3390/pharmaceutics14051048.
Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine.
Nowak-Stepniowska A, Osuchowska P, Fiedorowicz H, Trafny E
Stem Cells Int. 2022; 2022:8775591.
PMID: 35378955
PMC: 8976669.
DOI: 10.1155/2022/8775591.